Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07134634

Effect of a Vibrating Therapy Ball on Tremor and Daily Activities in Patients With Different Tremor Syndroms

Tremors, e.g. in patients with Parkinson's disease and essential tremor, are often pharmacoresistant, meaning that invasive treatment options such as deep brain stimulation are used at an early stage. Sufficient complementary non-pharmacological treatment alternatives do not yet exist. Patients with tremor are often severely restricted in their ability to carry out everyday activities and require support from relatives and carers, e.g. with food intake and hygiene measures.

The VILIM ball device is a CE-certified, non-invasive, portable physiotherapeutic aid. It is intended for use at home or in a professional setting as a mechanical vibration therapy device to temporarily reduce hand tremor.

With this vibrating therapy ball (VILIM tremor ball), which is customised to the patient's tremor during a training phase, should temporarily reduce tremor by up to 50%, according to the manufacturer. The effect can last up to 4 hours, so that patients should be able to carry out their everyday activities better, e.g. eating, writing, etc. (https://vilimed.com).

An initial study already reported a reduction in tremor in patients with Parkinson's disease and essential tremor. However, this study lacked a training phase, a control group and an examination of the effect on functions relevant to everyday life, meaning that reliable conclusions on the effect are only possible to a limited extent In this study, the influence of the portable physiotherapeutic therapy device (VILIM ball) on tremor in the upper extremity compared to an alternative therapy as a control condition in patients with Parkinson's tremor, essential tremor and other tremor syndromes will be investigated for the first time. The evaluation of the physician-associated scales will additionally be carried out by an independent physician in a single-blinded manner on the basis of video documentation.

The primary endpoint is a significant effect of the therapy ball on tremor, quantified and qualified using Clinical Global Impression Severity (CGI severity:

Assessment by doctor and patient) and validated disease-specific tremor scales: MDS-UPDRS IIl including the Tremor subscale, TETRAS between tremor ball therapy (Ball-On) alternative therapy (Ball-Off). Secondary endpoints include the effect of the therapy ball compared to the ball-off condition on tremor analysis data (e.g. frequency peak, amplitude) of an accelerometer, mini darts, writing tasks, specific tasks of daily life: e.g. bringing a spoon with liquid to the mouth, pouring water into a glass without losing the liquid and the success of the therapy using CGI improvement (doctor and patient).

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

ParkinsonBeelitzHeilstaetten

Beelitz, Brandenburg, 14547, Germany

Location status: Recruiting

Location contact

Doreen Gruber, MD

CONTACT

[email protected]

+493320422781

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of tremor
  • ability to complete the tests
  • no cognitive deficits relevant to everyday life

Exclusion criteria

  • cognitive deficits relevant to everyday life that influence therapy
  • pronounced dystonia, dyskinesia
  • Pregnancy
  • Acute thrombotic process (myocardial infarction, (acute vascular constriction)
  • Implants in activated regions of the body (e.g.artificial joints)
  • Acute inflammation of the locomotor system active arthrosis or arthropathy e.g. acute inflammationor swelling of joints
  • Acute tendinopathy in activated regions of the body (acute tendon inflammation)
  • Acute desmopathy (acute problems at the intervertebral disc)
  • Fresh fractures in activated regions of the body
  • Post-surgery wounds and fresh wounds in activated regions of the body or incomplete wound healing
  • Rheumatoid arthritis
  • Epilepsy.

Treatment and study plan

tremor device

Device

tremor ball on versus tremor ball off

Primary outcomes

  1. The effect of the vibrating therapy ball on hand tremor will be assessed before and after use, comparing ball-on vs. ball-off. The following scores will be used:

    Time frame: 2 years

    Primary endpoints:

    • Change in Clinical Global Impression Severity (Assessment by physician and patient) after using the therapy ball (Score 0 to 7 pts., a lower score means better outcome)
    • Change in MDS-UPDRS part IIl (Score 0 - 132 pts., a lower score means a better outcome)
    • Change in 2 items of TETRAS Activities of Daily Living Subscale (Score 0 -8 pts., a lower score means a better outcome)

    Secondary endpoints:

    • Changes in the frequency of the tremor (in Hz) using an acceleromter. A lower value means a better outcome
    • Changes in amplitude of the tremor (in mm) using an accelerometer. A lower value means a better outcome
    • changes in 3 items of Fahn-Tolosa-Marin-Tremor-Rating-Scale (0-12 pts.). A lower score means a better outcome
    • Change in Clinical Global Impression-Improvment Scale (CGI-I), (0-7 pts., lower score means better outcome

Study contacts

Contact information is provided by the study sponsor or research team.

Gruber, MD

CONTACT

[email protected]

+493320422781

Sponsors and collaborators

Lead sponsor

Parkinson's Clinic in Beelitz-Heilstatten

Other

Registry information

Official study title

Effekt Eines Vibrierenden Therapieballs Auf Den Tremor Und Alltagsaktivitäten Bei PatientInnen Mit Verschiedenen Tremorsyndromen

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Aug 21, 2025
Registry last updated
Aug 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.